Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Open Offer

27 Nov 2018 07:00

RNS Number : 5512I
Imaginatik PLC
27 November 2018
 

Imaginatik plc

("Imaginatik" or "the Company")

Result of Open Offer

 

On 2 November 2018 the Company announced details of an underwritten Open Offer to raise gross proceeds of up to approximately £252,578 through the issue of 22,961,687 new ordinary shares of £0.002 each ("Ordinary Shares") at 1.1 pence per share.

 

The Open Offer closed for acceptances at 11.00 a.m. on 26 November 2018 and the Company is pleased to announce that it has received valid acceptances under the Open Offer, including those received under the Excess Application Facility, in respect of 46,802,573 Ordinary Shares from Qualifying Shareholders. This represents demand for approximately 204 per cent. of the Open Offer Shares.

 

Qualifying Shareholders who have validly applied for Offer Shares will receive their Basic application in full and those Qualifying Shareholders who have validly applied for Excess Shares will receive approximately 33.10 per cent. of their Excess application on a pro rata basis, resulting in the issue of the full 22,961,687 Ordinary Shares under the Open Offer. Accordingly, the Company has not needed to call upon the underwriting facility.

 

Application has been made for the 22,961,687 new Ordinary Shares to be issued pursuant to the Open Offer to be admitted to trading on AIM. It is expected that admission of the new Ordinary Shares and commencement of dealings in the new Ordinary Shares will occur at 8.00 a.m. on 28 November 2018. Following Admission, the Enlarged Share Capital of the Company will consist of 71,949,673 Ordinary Shares. No Ordinary Shares are held in treasury.

 

The above figure of 71,949,673may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

This announcement should be read in conjunction with the full text of the Circular to Shareholders dated 2 November 2018, copies of which are available on the Company's website at www.imaginatik.com. Capitalised terms in this announcement have the same meaning as given in the Circular.

 

- ENDS -

 

For further information, please contact:

Imaginatik plc

Angus Forrest CEO

 

Via Alma PR (see contact details below)

WH Ireland - Nominated Adviser and joint broker

Mike Coe / Chris Savidge

 

Tel: +44 (0)117 945 3470

Peterhouse Capital Limited - Broker

Duncan Vasey / Lucy Williams

 

Tel: +44 (0) 20 7220 9797

Alma PR

Caroline Forde / Robyn Fisher

 

Tel: +44 (0) 20 8004 4218

 

About Imaginatik

 

Imaginatik is the only innovation solution provider which has combined a proven innovation program with purpose-built idea management software to enable companies to achieve breakthrough and continuous innovation at Imaginatik works with leading global enterprises to build and integrate innovation management skills as a core competency. Customers include ExxonMobil, Altria, TD Bank, Sodexo, Caterpillar and Cargill.

 

For more information visit www.imaginatik.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROILFFLLLTLRFIT
Date   Source Headline
15th Jun 20107:00 amRNSAppointment of Chief Operating Officer
1st Jun 20103:48 pmRNSHolding(s) in Company
13th May 20107:00 amRNSAppointment of Interim Vice President of Sales
6th May 20102:11 pmRNSHolding(s) in Company
28th Apr 20107:00 amRNSTrading Update
10th Mar 20107:00 amRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNSTrading Update
22nd Feb 20107:00 amRNSWindsor Foods Selects Imaginatik
17th Feb 20109:45 amRNSDirector Shareholding
29th Jan 201011:41 amRNSContract Win
22nd Dec 20097:00 amRNSDirectorate Change
17th Dec 20097:00 amRNSContract Win with Global Consumer Products Company
11th Dec 20097:00 amRNSContract Extension
17th Nov 20097:00 amRNSInterim Results
13th Nov 20097:00 amRNSContract Win
12th Nov 20097:00 amRNSNotice of Results
9th Oct 20097:00 amRNSTrading Update & Directorate Change
2nd Oct 20097:00 amRNSContract Win with global technology business
28th Sep 20097:00 amRNSContract Win with US Insurer
24th Sep 20097:00 amRNSDirector/PDMR Shareholding
23rd Sep 20097:00 amRNSProduct Launch
10th Sep 20097:00 amRNSContract Win
8th Sep 20097:00 amRNSWorld Economic Forum
13th Aug 20094:26 pmRNSHolding(s) in Company
13th Aug 20093:00 pmRNSHolding(s) in Company
13th Aug 200911:18 amRNSDirector/PDMR Shareholding
12th Aug 20095:17 pmRNSAdditional Listing
10th Aug 20097:00 amRNSPlacing
28th Jul 20097:00 amRNSAGM Statement
3rd Jul 20092:21 pmRNSDirector/PDMR - Share Subscription
29th Jun 20092:34 pmRNSAnnual Report & Accounts
17th Jun 20097:00 amRNSFinal Results
2nd Jun 20097:00 amRNSChange of Adviser & Notice of Results
15th May 200910:33 amRNSDirectorate Change
3rd Apr 20097:00 amRNSContract Win & Trading Update
19th Mar 20097:00 amRNSContract Extension with Chubb
5th Feb 20097:00 amRNSManagement Appointment
23rd Jan 20094:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20097:00 amRNSWorld Economic Forum
15th Jan 20097:00 amRNSTrading on PLUS
14th Jan 20093:10 pmRNSDirector/PDMR Shareholding
14th Jan 20097:00 amRNSPharmaceutical Contract Win
9th Jan 20099:09 amRNSDirector/PDMR Shareholding
7th Jan 20091:35 pmRNSDirector/PDMR Shareholding
5th Jan 200911:10 amRNSDirector/PDMR Shareholding
5th Jan 20099:40 amRNSDirector/PDMR Shareholding
2nd Jan 20099:05 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSTotal Voting Rights
24th Dec 200810:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.